News

Public · Published

BioMarin to Host Third Quarter 2026 Financial Results Conference Call and Webcast on Monday, November 2, 2026, at 4:30pm ET

BioMarin said CEO Alexander Hardy will host a conference call and webcast on Monday, November 2, 2026, at 4:30 p.m. ET to discuss third quarter 2026 financial results and give a general business update.

Published:

Updated:

What happened

BioMarin said CEO Alexander Hardy will host a conference call and webcast on Monday, November 2, 2026, at 4:30 p.m. ET to discuss third quarter 2026 financial results and give a general business update.

Confirmed

Global impact / market context

The call is when investors learn how much revenue BioMarin collected and what it spent in the quarter. Updates on its nine commercial therapies and pipeline can change expectations for future sales and costs, moving the stock.

Analyst inference

BioMarin is a rare disease biotechnology company, so investors value it on sales of existing medicines and progress of experimental ones. A scheduled results call lets holders and potential buyers reassess whether the current share price matches those prospects.

Analyst inference

What to watch

  1. The call is Monday, November 2, 2026, at 4:30 p.m. ET, with a replay archived on BioMarin's investor website for one week following the call. Confirmed
  2. Listen for third quarter 2026 revenue from BioMarin's nine commercial therapies, since slower sales would reduce cash available to fund research and could pressure the share price. Analyst inference
  3. Watch for commentary on research spending and pipeline progress, because higher costs or delayed programs could lower expected future profit and change how investors position in the stock. Proposed

Evidence

  • Original source link unavailable